AstraZeneca Pharma India Limited (the Company) has signed a Letter of Intent (LOI) with Strand Life Sciences Private Limited (Strand) to explore opportunities to collaborate in healthcare in India. Strand is described as a genomics research and diagnostics company and a subsidiary of Reliance Industries Limited.

The Company specifically disclosed that it and Strand are not related parties, and the execution of the LOI does not constitute a related party transaction.

Communication regarding this development was disseminated through the Company's LinkedIn handle and is accessible at https://www.linkedin.com/feed/update/urn:li:activity:7528370385122361344/. The information is also available on the Company's website at www.astrazeneca.com/india.

The disclosure was signed by Tanya Sanish, Company Secretary & Compliance Officer (ACS No. A25784), on November 17, 2026, at 15:04:56 +05:30. The communication was addressed to both BSE Limited and National Stock Exchange of India Limited for record purposes.